Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan: Goals of treatment and topical therapy

Hirokazu Arakawa, Naoki Shimojo, Norito Katoh, Kazumi Hiraba, Yasusuke Kawada, Keiichi Yamanaka, Ken Igawa, Hiroyuki Murota, Ikuo Okafuji, Tatsuki Fukuie, Takeshi Nakahara, Taro Noguchi, Akira Kanakubo, Ichiro Katayama

Research output: Contribution to journalArticle

Abstract

Background: Pediatric atopic dermatitis (PAD) is a pluricausal disease and is frequently seen in dermatological and pediatric practice. Therefore, it is important to find common views in clinical practice and to promote consensus among practitioners. Aiming to obtain common views among dermatologists and pediatricians and to disseminate them widely in clinical practice, we held the PAD Consensus Forums described herein. Methods: Questionnaire surveys of treatment goals and drug therapy were conducted to prepare topics for discussion at the PAD Consensus Forums. Reaching consensus was defined as agreement among at least 70% of the participants. Results: As a result of discussion among 24 dermatologists and 25 pediatricians, consensus was obtained on 7 topics. These topics configure 3 consensus of treatment goals (Attainment targets were divided into the short/medium term and the long term. Attainment targets were associated with the primary evaluation domains of the Harmonising Outcome Measures for Eczema (HOME) roadmap, etc.) and 4 consensus of drug therapy (The number of applications of topical anti-inflammatory drugs in the acute phase and selection and ideal intervals between applications of topical anti-inflammatory drugs in proactive therapy, etc.). Conclusions: The consensus is expected to help practitioners set appropriate treatment goals in clinical practice and facilitate the choice of drugs for treatment.

Original languageEnglish
Pages (from-to)84-90
Number of pages7
JournalAllergology International
Volume69
Issue number1
DOIs
Publication statusPublished - Jan 2020

Fingerprint

Atopic Dermatitis
Dermatology
Japan
Pediatrics
Anti-Inflammatory Agents
Pharmaceutical Preparations
Therapeutics
Drug Therapy
Eczema
Outcome Assessment (Health Care)
Dermatologists
Surveys and Questionnaires
Pediatricians

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy

Cite this

Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan : Goals of treatment and topical therapy. / Arakawa, Hirokazu; Shimojo, Naoki; Katoh, Norito; Hiraba, Kazumi; Kawada, Yasusuke; Yamanaka, Keiichi; Igawa, Ken; Murota, Hiroyuki; Okafuji, Ikuo; Fukuie, Tatsuki; Nakahara, Takeshi; Noguchi, Taro; Kanakubo, Akira; Katayama, Ichiro.

In: Allergology International, Vol. 69, No. 1, 01.2020, p. 84-90.

Research output: Contribution to journalArticle

Arakawa, H, Shimojo, N, Katoh, N, Hiraba, K, Kawada, Y, Yamanaka, K, Igawa, K, Murota, H, Okafuji, I, Fukuie, T, Nakahara, T, Noguchi, T, Kanakubo, A & Katayama, I 2020, 'Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan: Goals of treatment and topical therapy', Allergology International, vol. 69, no. 1, pp. 84-90. https://doi.org/10.1016/j.alit.2019.08.006
Arakawa, Hirokazu ; Shimojo, Naoki ; Katoh, Norito ; Hiraba, Kazumi ; Kawada, Yasusuke ; Yamanaka, Keiichi ; Igawa, Ken ; Murota, Hiroyuki ; Okafuji, Ikuo ; Fukuie, Tatsuki ; Nakahara, Takeshi ; Noguchi, Taro ; Kanakubo, Akira ; Katayama, Ichiro. / Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan : Goals of treatment and topical therapy. In: Allergology International. 2020 ; Vol. 69, No. 1. pp. 84-90.
@article{4c8a12333fcf413982251c8fc89f2b90,
title = "Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan: Goals of treatment and topical therapy",
abstract = "Background: Pediatric atopic dermatitis (PAD) is a pluricausal disease and is frequently seen in dermatological and pediatric practice. Therefore, it is important to find common views in clinical practice and to promote consensus among practitioners. Aiming to obtain common views among dermatologists and pediatricians and to disseminate them widely in clinical practice, we held the PAD Consensus Forums described herein. Methods: Questionnaire surveys of treatment goals and drug therapy were conducted to prepare topics for discussion at the PAD Consensus Forums. Reaching consensus was defined as agreement among at least 70{\%} of the participants. Results: As a result of discussion among 24 dermatologists and 25 pediatricians, consensus was obtained on 7 topics. These topics configure 3 consensus of treatment goals (Attainment targets were divided into the short/medium term and the long term. Attainment targets were associated with the primary evaluation domains of the Harmonising Outcome Measures for Eczema (HOME) roadmap, etc.) and 4 consensus of drug therapy (The number of applications of topical anti-inflammatory drugs in the acute phase and selection and ideal intervals between applications of topical anti-inflammatory drugs in proactive therapy, etc.). Conclusions: The consensus is expected to help practitioners set appropriate treatment goals in clinical practice and facilitate the choice of drugs for treatment.",
author = "Hirokazu Arakawa and Naoki Shimojo and Norito Katoh and Kazumi Hiraba and Yasusuke Kawada and Keiichi Yamanaka and Ken Igawa and Hiroyuki Murota and Ikuo Okafuji and Tatsuki Fukuie and Takeshi Nakahara and Taro Noguchi and Akira Kanakubo and Ichiro Katayama",
year = "2020",
month = "1",
doi = "10.1016/j.alit.2019.08.006",
language = "English",
volume = "69",
pages = "84--90",
journal = "Allergology International",
issn = "1323-8930",
publisher = "Japanese Society of Allergology",
number = "1",

}

TY - JOUR

T1 - Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan

T2 - Goals of treatment and topical therapy

AU - Arakawa, Hirokazu

AU - Shimojo, Naoki

AU - Katoh, Norito

AU - Hiraba, Kazumi

AU - Kawada, Yasusuke

AU - Yamanaka, Keiichi

AU - Igawa, Ken

AU - Murota, Hiroyuki

AU - Okafuji, Ikuo

AU - Fukuie, Tatsuki

AU - Nakahara, Takeshi

AU - Noguchi, Taro

AU - Kanakubo, Akira

AU - Katayama, Ichiro

PY - 2020/1

Y1 - 2020/1

N2 - Background: Pediatric atopic dermatitis (PAD) is a pluricausal disease and is frequently seen in dermatological and pediatric practice. Therefore, it is important to find common views in clinical practice and to promote consensus among practitioners. Aiming to obtain common views among dermatologists and pediatricians and to disseminate them widely in clinical practice, we held the PAD Consensus Forums described herein. Methods: Questionnaire surveys of treatment goals and drug therapy were conducted to prepare topics for discussion at the PAD Consensus Forums. Reaching consensus was defined as agreement among at least 70% of the participants. Results: As a result of discussion among 24 dermatologists and 25 pediatricians, consensus was obtained on 7 topics. These topics configure 3 consensus of treatment goals (Attainment targets were divided into the short/medium term and the long term. Attainment targets were associated with the primary evaluation domains of the Harmonising Outcome Measures for Eczema (HOME) roadmap, etc.) and 4 consensus of drug therapy (The number of applications of topical anti-inflammatory drugs in the acute phase and selection and ideal intervals between applications of topical anti-inflammatory drugs in proactive therapy, etc.). Conclusions: The consensus is expected to help practitioners set appropriate treatment goals in clinical practice and facilitate the choice of drugs for treatment.

AB - Background: Pediatric atopic dermatitis (PAD) is a pluricausal disease and is frequently seen in dermatological and pediatric practice. Therefore, it is important to find common views in clinical practice and to promote consensus among practitioners. Aiming to obtain common views among dermatologists and pediatricians and to disseminate them widely in clinical practice, we held the PAD Consensus Forums described herein. Methods: Questionnaire surveys of treatment goals and drug therapy were conducted to prepare topics for discussion at the PAD Consensus Forums. Reaching consensus was defined as agreement among at least 70% of the participants. Results: As a result of discussion among 24 dermatologists and 25 pediatricians, consensus was obtained on 7 topics. These topics configure 3 consensus of treatment goals (Attainment targets were divided into the short/medium term and the long term. Attainment targets were associated with the primary evaluation domains of the Harmonising Outcome Measures for Eczema (HOME) roadmap, etc.) and 4 consensus of drug therapy (The number of applications of topical anti-inflammatory drugs in the acute phase and selection and ideal intervals between applications of topical anti-inflammatory drugs in proactive therapy, etc.). Conclusions: The consensus is expected to help practitioners set appropriate treatment goals in clinical practice and facilitate the choice of drugs for treatment.

UR - http://www.scopus.com/inward/record.url?scp=85072389805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072389805&partnerID=8YFLogxK

U2 - 10.1016/j.alit.2019.08.006

DO - 10.1016/j.alit.2019.08.006

M3 - Article

AN - SCOPUS:85072389805

VL - 69

SP - 84

EP - 90

JO - Allergology International

JF - Allergology International

SN - 1323-8930

IS - 1

ER -